3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients maraviroc, Raltegravir, Darunavir/ritonavir - HIV-1 Adults Patients, AIDS | Phase 4 | Unknown | Fundación Huésped | 60 | 2010-02-01 | 2010-02-10 |
| Buprenorphine and Integrated HIV Care Evaluation Buprenorphine, Integrated HIV care and office-based opioid dependence treatment - Opioid-Related Disorders, HIV Infections | Phase 4 | Unknown | The New York Academy of Medicine | 1350 | 2005-08-01 | 2007-03-27 |
| Once Daily 3TC, Efavirenz and ddI for HIV Infection once daily minimum 3-drug regimen of anti-retroviral medications - HIV Infection, AIDS | Phase 4 | Unknown | 407 Doctors | 120 | 2004-05-01 | 2005-10-25 |
Acquired Immunodeficiency Syndrome (3) · HIV Infections (2) · Opioid-Related Disorders (1) · Substance-Related Disorders (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases (3) · Sexually Transmitted Diseases, Viral (3) · Slow Virus Diseases (3) · Urogenital Diseases (3) · Virus Diseases (3) · Chemically-Induced Disorders (1)
Buprenorphine (1) · Darunavir (1) · Maraviroc (1) · Raltegravir Potassium (1) · Ritonavir (1)
407 Doctors (1) · Fundación Huésped (1) · The New York Academy of Medicine (1)
Argentina (1) · Australia (1) · United States (1)
David A Baker, MB ChB (1) · David Fiellin, MD (1) · Ruth Finkelstein, ScD (1)